Press release
UK HIV Diagnostic Market Growing Trade Among Emerging Economies Opening New Opportunities
The UK HIV Diagnostic Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global UK HIV Diagnostic market. This report explores all the key factors affecting the growth of the global UK HIV Diagnostic market, including demand-supply scenario, pricing structure, profit margins, production, and value chain analysis.
Get PDF Sample Report Now! @ https://www.prudentmarkets.com/sample-request/141801/
Report Description of the UK HIV Diagnostic Market Analysis
Research Scope and Assumption
The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
Inflation has not been accounted for in order to estimate and forecast the market
Numbers may not add up due to rounding off
Reason to buy the report:
Facilitate decision-making based on strong current and forecast data for UK HIV Diagnostic Market Analysis
Develop strategies based on the latest regulatory framework
Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the UK HIV Diagnostic Market Analysis
Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
To strategically profile key players and comprehensively analyze their market shares and core competencies
We have technically sound team which do a deep dive research and also provide strategy based consulting analysis
UK HIV Diagnostic Market Analysis Executive Summary
The United Kingdom (UK) has a relatively small, concentrated HIV epidemic, with an estimated 101,600 people living with HIV in 2017. This translates into an HIV prevalence of 1.7 per 1,000 people of all ages or 2.2 per 1,000 of people aged 15-74 years. In the same year, 4,363 people were newly diagnosed with HIV, a number that is steadily declining each year, falling by 17% between 2016 and 2017 alone. This is largely due to the decrease in new diagnoses among and bisexual men, the group most affected by HIV in the UK, which fell by almost a third (31%) between 2015 and 2017
Market Size and Key Findings
The UK HIV Diagnostic Market Analysis size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Market Dynamics
Market Growth Drivers Analysis
Pre-exposure prophylaxis (PrEP) is a daily course of antiretroviral drugs (ARVs) that can protect HIV-negative people from HIV. PrEP use in England is thought to have quadrupled during 2016 due to online purchasing amongbisexual men, which resulted in around 3,000 bisexual men taking PrEP by the end of that year. In October 2017, a three-year PrEP trial began across 200 sexual health clinics in England, meaning it was then nationally available. Previously, the NHS in England had said that it could not PrEP, however this decision not was overturned in court. The last measure of needle and syringe programme (NSPs) coverage in the UK was in 2006. At the time, 80% of NSPs were pharmacy-based while the remainder were specialist centres. In 2014, National Institute for Health and Care Excellence (NICE) released new guidance on the provision of NSPs calling for a better mix of services. Opioid substitution therapy (OST) is widely available in the UK and tends to be dispensed by community-based pharmacists. In the UK, state schools have to provide sex and relationship education (SRE) but private schools do not. Parents also have the right to withdraw their children from SRE, though few do so. In the early years of the HIV epidemic, there were a number of high-profile awareness campaigns in the UK that warned the public about how HIV is transmitted and calling for people to adopt safer sex behaviours.
Market Restraints
The UK Stigma Index 2015, a survey of more than 1,500 people living with HIV, found that a considerable number of people hold stigmatising attitudes towards those living with HIV. Around one in five people reported being excluded from family events because of their HIV status and 20% reported sexual rejection after telling someone their status. A third of all participants feared being rejected by a sexual partner (35%) and had avoided sexual encounters (33%) in the last 12 months due to their status. A new HIV Stigma Index survey is being carried out in 2019. There is also evidence that levels of HIV knowledge among the UK public is low. A survey by the National AIDS Trust in 2014 found that only 45% of people could correctly identify all of the ways HIV is and is not transmitted, and an increasing proportion incorrectly believed it can be transmitted via routes like kissing (16%). While HIV treatment was made free to people from overseas in 2012, many migrants living with HIV in the UK face other difficulties in accessing treatment, care and support. Undocumented migrants in particular find it difficult to register with a local General Practioner (GP): they are often required to prove their identity and do not understand NHS entitlement rules or how to apply for treatment.
COVID-19 impact on "UK HIV Diagnostic Market Analysis
The year 2020 was dominated by the COVID - 19 pandemic as nearly two million people are infected by Coronavirus. On one hand, diagnostics, PPE equipment, critical medical supplies gained unprecedented demand while medical procedures declined by around 50% to 60% based on the market. The report presents the impact of the pandemic and recovery scenarios for HIV/AIDS Diagnostics over the forecast period to 2028. As companies realign their resources to operate under the limitations imposed by the pandemic, the report presents three scenarios of market recovery - Low Growth, Reference Case, and High Growth scenarios. The cases consider supply chain disruptions, consumer confidence, economic impact, and overall industry recovery factors.
Products in Pipeline
Projects included PROMOTE, which targeted male sex workers in Bristol through online outreach and peer-support groups, and a radio and podcast series for prisoners to dispel myths about HIV. Projects receiving funding between 2018 and 2019 include The Grass is Always Grindr, a weekly YouTube drama about a group of young men living in London, and Catwalks for Power, which aims to empower marginalized women living with HIV.
Notable Recent Deals
In 2015, Public Health England began an HIV Prevention Innovation Fund to support community-led approaches to HIV prevention. Between 2017 and 2018 the fund reached around 170,000 people most affected by HIV in the UK.
Healthcare Policies and Regulatory Landscape
Policy changes and Reimbursement scenario
COVID-19 risks exacerbating the situation. WHO recently developed guidance for countries on how to safely maintain access to essential health services during the pandemic, including for all people living with or affected by HIV. The guidance encourages countries to limit disruptions in access to HIV treatment through multi-month dispensing, a policy whereby medicines are prescribed for longer periods of time up to six months. To date, 129 countries have adopted this policy. Countries are also mitigating the impact of the disruptions by working to maintain flights and supply chains, engaging communities in the delivery of HIV medicines, and working with manufacturers to overcome logistics challenges..
To Know More About COVID-19 Impact On UK HIV Diagnostic Market @ https://www.prudentmarkets.com/sample-request/141801/
UK HIV Diagnostic Market Analysis Segmentation
By Product
Consumables
Instruments
Software & Services
By Type:
Antibody Tests
Viral Identification Tests
CD4 Testing
Viral Load Testing
Early Infant Diagnostics
By End-User:
Diagnostic Laboratories
Hospitals
Blood Banks
Home Care Settings
Other End users
Prudent Markets provides attractive discounts that fit your needs. Customization of the reports as per your requirement is also offered. Get in touch with our sales team, who will guarantee you a report that suits your needs.
Speak To Our Analyst For A Discussion On The Above Findings, And Ask For A Discount On The Report @ https://www.prudentmarkets.com/discount-request/141801/
The report covers the competitive analysis of the market. As the demand is driven by a buyer's paying capacity and the rate of item development, the report shows the important regions that will direct growth. This section exclusively shares insight into the budget reports of big-league members of the market helping key players and new entrants understand the potential of investments in the Global UK HIV Diagnostic Market. It can be better employed by both traditional and new players in the industry for complete know-how of the market.
Strategic Points Covered in Table of Content of Global UK HIV Diagnostic Market:
Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the UK HIV Diagnostic market
Chapter 2: Exclusive Summary - the basic information of the UK HIV Diagnostic Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the UK HIV Diagnostic
Chapter 4: Presenting the UK HIV Diagnostic Market Factor Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User and Region/Country
Chapter 6: Evaluating the leading manufacturers of the UK HIV Diagnostic market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions
Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source
Any Questions? Feel Free To Enquire Here. We Will put you on the Right Path @ https://www.prudentmarkets.com/enquiry-request/141801/
Free Customization on the basis of client requirements on Immediate purchase:
1- Free country-level breakdown of any 5 countries of your interest.
2- Competitive breakdown of segment revenue by market players.
Customization of the Report:
This report can be customized to meet the client's requirements. Please connect with our sales team (sales@prudentmarkets.com), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +91 83560 50278 || USA/Canada(Toll Free): 1800-601-6071 to share your research requirements.
Get ready to Recognize the pros and cons of the regulatory framework, local reforms, and its effect on the Industry. Understand how the Leaders in Intelligent Network are keeping themselves one stage forward with our most up-to-date survey analysis.
In conclusion, the UK HIV Diagnostic Market report is a genuine source for accessing the research data which is projected to exponentially grow your business. The report provides information such as economic scenarios, benefits, limits, trends, market growth rates, and figures. SWOT analysis and PESTLE analysis is also incorporated in the report
Contact Us:
Allan Carter
Andheri, Maharashtra, 400102
USA/Canada(Toll Free): 1800-601-6071
Direct Line: +91 83560 50278
Mail: sales@prudentmarkets.com
Web: www.prudentmarkets.com
About Us:
We are leaders in market analytics, business research, and consulting services for Fortune 500 companies, start-ups, financial & government institutions. Since we understand the criticality of data and insights, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. To be at our client's disposal whenever they need help on market research and consulting services. We also aim to be their business partners when it comes to making critical business decisions around new market entry, M&A, competitive Intelligence and strategy.
Get PDF Sample Report Now! @ https://www.prudentmarkets.com/sample-request/141801/
Report Description of the UK HIV Diagnostic Market Analysis
Research Scope and Assumption
The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
Inflation has not been accounted for in order to estimate and forecast the market
Numbers may not add up due to rounding off
Reason to buy the report:
Facilitate decision-making based on strong current and forecast data for UK HIV Diagnostic Market Analysis
Develop strategies based on the latest regulatory framework
Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the UK HIV Diagnostic Market Analysis
Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
To strategically profile key players and comprehensively analyze their market shares and core competencies
We have technically sound team which do a deep dive research and also provide strategy based consulting analysis
UK HIV Diagnostic Market Analysis Executive Summary
The United Kingdom (UK) has a relatively small, concentrated HIV epidemic, with an estimated 101,600 people living with HIV in 2017. This translates into an HIV prevalence of 1.7 per 1,000 people of all ages or 2.2 per 1,000 of people aged 15-74 years. In the same year, 4,363 people were newly diagnosed with HIV, a number that is steadily declining each year, falling by 17% between 2016 and 2017 alone. This is largely due to the decrease in new diagnoses among and bisexual men, the group most affected by HIV in the UK, which fell by almost a third (31%) between 2015 and 2017
Market Size and Key Findings
The UK HIV Diagnostic Market Analysis size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Market Dynamics
Market Growth Drivers Analysis
Pre-exposure prophylaxis (PrEP) is a daily course of antiretroviral drugs (ARVs) that can protect HIV-negative people from HIV. PrEP use in England is thought to have quadrupled during 2016 due to online purchasing amongbisexual men, which resulted in around 3,000 bisexual men taking PrEP by the end of that year. In October 2017, a three-year PrEP trial began across 200 sexual health clinics in England, meaning it was then nationally available. Previously, the NHS in England had said that it could not PrEP, however this decision not was overturned in court. The last measure of needle and syringe programme (NSPs) coverage in the UK was in 2006. At the time, 80% of NSPs were pharmacy-based while the remainder were specialist centres. In 2014, National Institute for Health and Care Excellence (NICE) released new guidance on the provision of NSPs calling for a better mix of services. Opioid substitution therapy (OST) is widely available in the UK and tends to be dispensed by community-based pharmacists. In the UK, state schools have to provide sex and relationship education (SRE) but private schools do not. Parents also have the right to withdraw their children from SRE, though few do so. In the early years of the HIV epidemic, there were a number of high-profile awareness campaigns in the UK that warned the public about how HIV is transmitted and calling for people to adopt safer sex behaviours.
Market Restraints
The UK Stigma Index 2015, a survey of more than 1,500 people living with HIV, found that a considerable number of people hold stigmatising attitudes towards those living with HIV. Around one in five people reported being excluded from family events because of their HIV status and 20% reported sexual rejection after telling someone their status. A third of all participants feared being rejected by a sexual partner (35%) and had avoided sexual encounters (33%) in the last 12 months due to their status. A new HIV Stigma Index survey is being carried out in 2019. There is also evidence that levels of HIV knowledge among the UK public is low. A survey by the National AIDS Trust in 2014 found that only 45% of people could correctly identify all of the ways HIV is and is not transmitted, and an increasing proportion incorrectly believed it can be transmitted via routes like kissing (16%). While HIV treatment was made free to people from overseas in 2012, many migrants living with HIV in the UK face other difficulties in accessing treatment, care and support. Undocumented migrants in particular find it difficult to register with a local General Practioner (GP): they are often required to prove their identity and do not understand NHS entitlement rules or how to apply for treatment.
COVID-19 impact on "UK HIV Diagnostic Market Analysis
The year 2020 was dominated by the COVID - 19 pandemic as nearly two million people are infected by Coronavirus. On one hand, diagnostics, PPE equipment, critical medical supplies gained unprecedented demand while medical procedures declined by around 50% to 60% based on the market. The report presents the impact of the pandemic and recovery scenarios for HIV/AIDS Diagnostics over the forecast period to 2028. As companies realign their resources to operate under the limitations imposed by the pandemic, the report presents three scenarios of market recovery - Low Growth, Reference Case, and High Growth scenarios. The cases consider supply chain disruptions, consumer confidence, economic impact, and overall industry recovery factors.
Products in Pipeline
Projects included PROMOTE, which targeted male sex workers in Bristol through online outreach and peer-support groups, and a radio and podcast series for prisoners to dispel myths about HIV. Projects receiving funding between 2018 and 2019 include The Grass is Always Grindr, a weekly YouTube drama about a group of young men living in London, and Catwalks for Power, which aims to empower marginalized women living with HIV.
Notable Recent Deals
In 2015, Public Health England began an HIV Prevention Innovation Fund to support community-led approaches to HIV prevention. Between 2017 and 2018 the fund reached around 170,000 people most affected by HIV in the UK.
Healthcare Policies and Regulatory Landscape
Policy changes and Reimbursement scenario
COVID-19 risks exacerbating the situation. WHO recently developed guidance for countries on how to safely maintain access to essential health services during the pandemic, including for all people living with or affected by HIV. The guidance encourages countries to limit disruptions in access to HIV treatment through multi-month dispensing, a policy whereby medicines are prescribed for longer periods of time up to six months. To date, 129 countries have adopted this policy. Countries are also mitigating the impact of the disruptions by working to maintain flights and supply chains, engaging communities in the delivery of HIV medicines, and working with manufacturers to overcome logistics challenges..
To Know More About COVID-19 Impact On UK HIV Diagnostic Market @ https://www.prudentmarkets.com/sample-request/141801/
UK HIV Diagnostic Market Analysis Segmentation
By Product
Consumables
Instruments
Software & Services
By Type:
Antibody Tests
Viral Identification Tests
CD4 Testing
Viral Load Testing
Early Infant Diagnostics
By End-User:
Diagnostic Laboratories
Hospitals
Blood Banks
Home Care Settings
Other End users
Prudent Markets provides attractive discounts that fit your needs. Customization of the reports as per your requirement is also offered. Get in touch with our sales team, who will guarantee you a report that suits your needs.
Speak To Our Analyst For A Discussion On The Above Findings, And Ask For A Discount On The Report @ https://www.prudentmarkets.com/discount-request/141801/
The report covers the competitive analysis of the market. As the demand is driven by a buyer's paying capacity and the rate of item development, the report shows the important regions that will direct growth. This section exclusively shares insight into the budget reports of big-league members of the market helping key players and new entrants understand the potential of investments in the Global UK HIV Diagnostic Market. It can be better employed by both traditional and new players in the industry for complete know-how of the market.
Strategic Points Covered in Table of Content of Global UK HIV Diagnostic Market:
Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the UK HIV Diagnostic market
Chapter 2: Exclusive Summary - the basic information of the UK HIV Diagnostic Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the UK HIV Diagnostic
Chapter 4: Presenting the UK HIV Diagnostic Market Factor Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User and Region/Country
Chapter 6: Evaluating the leading manufacturers of the UK HIV Diagnostic market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions
Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source
Any Questions? Feel Free To Enquire Here. We Will put you on the Right Path @ https://www.prudentmarkets.com/enquiry-request/141801/
Free Customization on the basis of client requirements on Immediate purchase:
1- Free country-level breakdown of any 5 countries of your interest.
2- Competitive breakdown of segment revenue by market players.
Customization of the Report:
This report can be customized to meet the client's requirements. Please connect with our sales team (sales@prudentmarkets.com), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +91 83560 50278 || USA/Canada(Toll Free): 1800-601-6071 to share your research requirements.
Get ready to Recognize the pros and cons of the regulatory framework, local reforms, and its effect on the Industry. Understand how the Leaders in Intelligent Network are keeping themselves one stage forward with our most up-to-date survey analysis.
In conclusion, the UK HIV Diagnostic Market report is a genuine source for accessing the research data which is projected to exponentially grow your business. The report provides information such as economic scenarios, benefits, limits, trends, market growth rates, and figures. SWOT analysis and PESTLE analysis is also incorporated in the report
Contact Us:
Allan Carter
Andheri, Maharashtra, 400102
USA/Canada(Toll Free): 1800-601-6071
Direct Line: +91 83560 50278
Mail: sales@prudentmarkets.com
Web: www.prudentmarkets.com
About Us:
We are leaders in market analytics, business research, and consulting services for Fortune 500 companies, start-ups, financial & government institutions. Since we understand the criticality of data and insights, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. To be at our client's disposal whenever they need help on market research and consulting services. We also aim to be their business partners when it comes to making critical business decisions around new market entry, M&A, competitive Intelligence and strategy.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
